| scholarly article | Q13442814 |
| P50 | author | Cecilia Giulivi | Q30511277 |
| P2093 | author name string | Flora Tassone | |
| Randi Hagerman | |||
| Eleonora Napoli | |||
| Julian Halmai | |||
| P2860 | cites work | HMDB: the Human Metabolome Database | Q23039065 |
| Molecular markers of early Parkinson's disease based on gene expression in blood | Q24292810 | ||
| Cognitive, anxiety and mood disorders in the fragile X-associated tremor/ataxia syndrome | Q24567980 | ||
| HMDB 3.0--The Human Metabolome Database in 2013 | Q24595162 | ||
| Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression | Q24654019 | ||
| HMDB: a knowledgebase for the human metabolome | Q24655295 | ||
| RNA editing by adenosine deaminases that act on RNA | Q24679593 | ||
| Regulation of stearoyl-CoA desaturase-1 after central and peripheral nerve lesions | Q24798942 | ||
| Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice | Q24805374 | ||
| The Chemical Translation Service--a web-based tool to improve standardization of metabolomic reports | Q27062596 | ||
| Redox-switch modulation of human SSADH by dynamic catalytic loop | Q27654216 | ||
| Defects in purine nucleotide metabolism lead to substantial incorporation of xanthine and hypoxanthine into DNA and RNA | Q27939142 | ||
| PubChem Substance and Compound databases | Q27942588 | ||
| Omega-3 fatty acids reverse age-related decreases in nuclear receptors and increase neurogenesis in old rats | Q28277698 | ||
| Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women | Q28476486 | ||
| Biochemical similarities and differences between the catalytic [4Fe-4S] cluster containing fumarases FumA and FumB from Escherichia coli | Q28485987 | ||
| Premutation in the Fragile X Mental Retardation 1 (FMR1) Gene Affects Maternal Zn-milk and Perinatal Brain Bioenergetics and Scaffolding | Q30008925 | ||
| Developmental trends in auditory processing can provide early predictions of language acquisition in young infants | Q30442243 | ||
| Metabolomics by numbers: acquiring and understanding global metabolite data | Q30925430 | ||
| Elevated sorbitol concentration in the cerebrospinal fluid of patients with mood disorders | Q31391381 | ||
| Mass spectrometry for the identification of the discriminating signals from metabolomics: current status and future trends | Q33440434 | ||
| Evidence of mitochondrial dysfunction in fragile X-associated tremor/ataxia syndrome | Q33570563 | ||
| Clinical involvement in daughters of men with fragile X-associated tremor ataxia syndrome | Q33650175 | ||
| Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates | Q33905067 | ||
| Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. | Q34146206 | ||
| Age-related changes of n-3 and n-6 polyunsaturated fatty acids in the anterior cingulate cortex of individuals with major depressive disorder | Q34201567 | ||
| Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation | Q44521568 | ||
| Heterozygous fragile X female: historical, physical, cognitive, and cytogenetic features | Q45270211 | ||
| Subchronic alpha-linolenic acid treatment enhances brain plasticity and exerts an antidepressant effect: a versatile potential therapy for stroke. | Q45916414 | ||
| Brain structure in asymptomatic FMR1 premutation carriers at risk for fragile X-associated tremor/ataxia syndrome. | Q45981668 | ||
| Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: An in situ cerebral perfusion study. | Q46011960 | ||
| Discovery of metabolomics biomarkers for early detection of nephrotoxicity | Q46043673 | ||
| Effects of brain-derived neurotrophic factor on optic axon branching and remodelling in vivo | Q46119326 | ||
| Omega-3 polyunsaturated fatty acids increase the neurite outgrowth of rat sensory neurones throughout development and in aged animals. | Q46488016 | ||
| Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis | Q46574227 | ||
| Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. | Q46666276 | ||
| Impact of the Fragile X mental retardation 1 (FMR1) gene premutation on neuropsychiatric functioning in adult males without fragile X-associated Tremor/Ataxia syndrome: a controlled study | Q46827956 | ||
| BDNF-dependent accumulation of palmitoleic acid in CNS neurons | Q47322720 | ||
| Polyunsaturated fatty acids and brain white matter anisotropy in recent-onset schizophrenia: a preliminary study. | Q48596626 | ||
| Endogenous conversion of omega-6 into omega-3 fatty acids improves neuropathology in an animal model of Alzheimer's disease. | Q48901597 | ||
| Some subtypes of endocannabinoid/endovanilloid receptors mediate docosahexaenoic acid-induced enhanced spatial memory in rats. | Q48974786 | ||
| Skewed X Inactivation in Women Carrying the FMR1 Premutation and Its Relation with Fragile-X-Associated Tremor/Ataxia Syndrome. | Q50243801 | ||
| Motor and mental dysfunction in mother-daughter transmitted FXTAS. | Q50267098 | ||
| Fragile X-associated tremor/ataxia syndrome in sisters related to X-inactivation. | Q50282509 | ||
| Biochemical abnormalities in Pearson syndrome. | Q53612700 | ||
| Carnosine protects neurons against oxidative stress and modulates the time profile of MAPK cascade signaling. | Q54548573 | ||
| Immune-mediated disorders among women carriers of fragile X premutation alleles. | Q55637365 | ||
| Malondialdehyde scavenging and aldose-derived Schiff bases’ transglycation properties of synthetic histidyl-hydrazide carnosine analogs | Q58201423 | ||
| Non-invasive evaluation of portal-systemic shunting in man by D-sorbitol bioavailability | Q69474344 | ||
| Mass spectrometry-based metabolomics: accelerating the characterization of discriminating signals by combining statistical correlations and ultrahigh resolution | Q81361410 | ||
| Short-term long chain omega3 diet protects from neuroinflammatory processes and memory impairment in aged mice. | Q34290929 | ||
| Carnosine: a versatile antioxidant and antiglycating agent | Q34416166 | ||
| Metabolomics: building on a century of biochemistry to guide human health | Q34591242 | ||
| Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics. | Q34735142 | ||
| Prostaglandins and other lipid mediators in Alzheimer's disease | Q34997956 | ||
| Altered zinc transport disrupts mitochondrial protein processing/import in fragile X-associated tremor/ataxia syndrome | Q35090105 | ||
| Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease | Q35287117 | ||
| Regulation of stearoyl-CoA desaturases and role in metabolism | Q35599793 | ||
| Prevalence of CGG expansions of the FMR1 gene in a US population-based sample | Q36082674 | ||
| A defect in the activity of Delta6 and Delta5 desaturases may be a factor predisposing to the development of insulin resistance syndrome | Q36105719 | ||
| Low unesterified:esterified eicosapentaenoic acid (EPA) plasma concentration ratio is associated with bipolar disorder episodes, and omega-3 plasma concentrations are altered by treatment | Q36217965 | ||
| Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease. | Q36226179 | ||
| Mitochondrial Citrate Transporter-dependent Metabolic Signature in the 22q11.2 Deletion Syndrome | Q36281669 | ||
| Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? | Q36295313 | ||
| Young adult male carriers of the fragile X premutation exhibit genetically modulated impairments in visuospatial tasks controlled for psychomotor speed | Q36423826 | ||
| KEGG as a reference resource for gene and protein annotation | Q36434599 | ||
| Graph-based methods for analysing networks in cell biology | Q36552759 | ||
| Early mitochondrial abnormalities in hippocampal neurons cultured from Fmr1 pre-mutation mouse model | Q36588189 | ||
| Metabolomic analysis and signatures in motor neuron disease | Q36908588 | ||
| Granulosa cell and oocyte mitochondrial abnormalities in a mouse model of fragile X primary ovarian insufficiency. | Q36946491 | ||
| Cerebrospinal fluid evidence of increased extra-mitochondrial glucose metabolism implicates mitochondrial dysfunction in multiple sclerosis disease progression | Q36975562 | ||
| Plasma Biomarkers for Monitoring Brain Pathophysiology in FMR1 Premutation Carriers. | Q37168478 | ||
| Alzheimer's disease beyond the genomic era: nuclear magnetic resonance (NMR) spectroscopy-based metabolomics. | Q37191378 | ||
| Altered redox mitochondrial biology in the neurodegenerative disorder fragile X-tremor/ataxia syndrome: use of antioxidants in precision medicine. | Q37370534 | ||
| Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome | Q37580522 | ||
| Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS. | Q37663133 | ||
| Metabolomics for early detection of drug-induced kidney injury: review of the current status | Q37810166 | ||
| Quality control for plant metabolomics: reporting MSI-compliant studies | Q38502318 | ||
| A global test for groups of genes: testing association with a clinical outcome | Q38522319 | ||
| Warburg effect linked to cognitive-executive deficits in FMR1 premutation | Q39661355 | ||
| Analysis of the adult human plasma metabolome | Q40107287 | ||
| Polyunsaturated fatty acid deficit in patients with bipolar mania | Q40598954 | ||
| Cognitive dysfunction resulting from hippocampal hyperactivity--a possible cause of anxiety disorder? | Q41454704 | ||
| Altered Bioenergetics in Primary Dermal Fibroblasts from Adult Carriers of the FMR1 Premutation Before the Onset of the Neurodegenerative Disease Fragile X-Associated Tremor/Ataxia Syndrome | Q41637163 | ||
| Modulation of mitochondrial function and autophagy mediates carnosine neuroprotection against ischemic brain damage | Q41827290 | ||
| n-3 PUFA status affects expression of genes involved in neuroenergetics differently in the fronto-parietal cortex compared to the CA1 area of the hippocampus: effect of rest and neuronal activation in the rat. | Q42506215 | ||
| Lipid alterations in lipid rafts from Alzheimer's disease human brain cortex | Q43181451 | ||
| Fragile X premutation in a woman with cognitive impairment, tremor, and history of premature ovarian failure | Q44373619 | ||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neurodegeneration | Q1755122 |
| P304 | page(s) | 3871-3888 | |
| P577 | publication date | 2016-08-23 | |
| P1433 | published in | Biochemical Journal | Q864221 |
| P1476 | title | Plasma metabolic profile delineates roles for neurodegeneration, pro-inflammatory damage and mitochondrial dysfunction in the FMR1 premutation | |
| P478 | volume | 473 |
| Q60311366 | Allopregnanolone Treatment Improves Plasma Metabolomic Profile Associated with GABA Metabolism in Fragile X-Associated Tremor/Ataxia Syndrome: a Pilot Study |
| Q59806856 | Fragile X Associated Primary Ovarian Insufficiency (FXPOI): Case Report and Literature Review |
| Q92575202 | Fragile X syndrome and associated disorders: Clinical aspects and pathology |
| Q89848611 | Fragile X- associated Neuropsychiatric Disorders: A Case Report |
| Q57167370 | Impact of Premutation on Neurobehavior and Bioenergetics in Young Monozygotic Twins |
| Q93370188 | Metabolic pathways modulate the neuronal toxicity associated with fragile X-associated tremor/ataxia syndrome |
| Q64791367 | Microglial cell activation and senescence are characteristic of the pathology FXTAS |
| Q58719610 | Presence of Middle Cerebellar Peduncle Sign in Premutation Carriers Without Tremor and Ataxia |
| Q49828884 | Redox Status, Procoagulant Activity, and Metabolome of Fresh Frozen Plasma in Glucose 6-Phosphate Dehydrogenase Deficiency. |
| Q49905433 | Repeat-associated non-AUG (RAN) translation and other molecular mechanisms in Fragile X Tremor Ataxia Syndrome. |
Search more.